KC
Highly rated in
23
conditions
Highly rated in
23
conditions
Check Dr. Karen G. Chee's experience treating your condition:
About Dr. Karen G. Chee

Karen Chee is an Oncologist and a Hematologist Oncology expert in San Mateo, California. Chee has been practicing medicine for over 21 years and is highly rated in 23 conditions, according to our data. Her top areas of expertise are Essential Thrombocythemia, Colorectal Cancer, Familial Colorectal Cancer, and Pancreatoblastoma. She is licensed to treat patients in California. Chee is currently accepting new patients.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Karen G. Chee it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Karen G. Chee accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
218 De Anza Blvd, San Mateo, CA 94402
Other Locations
1825 Fourth St., Fourth Floor, San Francisco, CA 94158
400 Parnassus Ave., Fourth Floor, San Francisco, CA 94143
Background & Education
Graduate Institution
University Of California, Davis School Of Medicine, 2001
Specialties
Oncology
Hematology Oncology
Hematology
Licenses
Internal Medicine in CA
Hospital Affiliations
UCSF Helen Diller Medical Center At Parnassus Heights
Sequoia Hospital
UCSF Medical Center At Mount Zion
Mills-Peninsula Medical Center
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors